These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 38780838)
1. Analysis of the interaction of antimalarial agents with Plasmodium falciparum glutathione reductase through molecular mechanical calculations. Ferreira FHDC; Pinto LR; Oliveira BA; Daniel LV; Navarro M; Delgado GYS J Mol Model; 2024 May; 30(6):181. PubMed ID: 38780838 [TBL] [Abstract][Full Text] [Related]
2. Targeting the intersubunit cavity of Plasmodium falciparum glutathione reductase by a novel natural inhibitor: computational and experimental evidence. Tyagi C; Bathke J; Goyal S; Fischer M; Dahse HM; Chacko S; Becker K; Grover A Int J Biochem Cell Biol; 2015 Apr; 61():72-80. PubMed ID: 25660424 [TBL] [Abstract][Full Text] [Related]
3. Development of a functional assay to detect inhibitors of Plasmodium falciparum glutathione reductase utilizing liquid chromatography-mass spectrometry. Burkard L; Scheuermann A; Simithy J; Calderón AI Biomed Chromatogr; 2016 Apr; 30(4):543-7. PubMed ID: 26257195 [TBL] [Abstract][Full Text] [Related]
4. Antiplasmodial Activity of Nitroaromatic Compounds: Correlation with Their Reduction Potential and Inhibitory Action on Marozienė A; Lesanavičius M; Davioud-Charvet E; Aliverti A; Grellier P; Šarlauskas J; Čėnas N Molecules; 2019 Dec; 24(24):. PubMed ID: 31835450 [TBL] [Abstract][Full Text] [Related]
5. Double-drug development against antioxidant enzymes from Plasmodium falciparum. Biot C; Dessolin J; Grellier P; Davioud-Charvet E Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365 [TBL] [Abstract][Full Text] [Related]
6. A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline. Davioud-Charvet E; Delarue S; Biot C; Schwöbel B; Boehme CC; Müssigbrodt A; Maes L; Sergheraert C; Grellier P; Schirmer RH; Becker K J Med Chem; 2001 Nov; 44(24):4268-76. PubMed ID: 11708927 [TBL] [Abstract][Full Text] [Related]
7. Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. Färber PM; Arscott LD; Williams CH; Becker K; Schirmer RH FEBS Lett; 1998 Feb; 422(3):311-4. PubMed ID: 9498806 [TBL] [Abstract][Full Text] [Related]
8. Docking studies and development of novel 5-heteroarylamino-2,4-diamino-8-chloropyrimido-[4,5-b]quinolines as potential antimalarials. Joshi AA; Viswanathan CL Bioorg Med Chem Lett; 2006 May; 16(10):2613-7. PubMed ID: 16516468 [TBL] [Abstract][Full Text] [Related]
9. Rational Optimization of Dihydropyrimidinone-Quinoline Hybrids as Plasmodium falciparum Glutathione Reductase Inhibitors. Adigun RA; Malan FP; Balogun MO; October N ChemMedChem; 2022 May; 17(10):e202200034. PubMed ID: 35195955 [TBL] [Abstract][Full Text] [Related]
10. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH). Saxena S; Durgam L; Guruprasad L J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775 [TBL] [Abstract][Full Text] [Related]
11. Docking, QM/MM, and molecular dynamics simulations of the hexose transporter from Plasmodium falciparum (PfHT). Fonseca AL; Nunes RR; Braga VM; Comar M; Alves RJ; Varotti Fde P; Taranto AG J Mol Graph Model; 2016 May; 66():174-86. PubMed ID: 27131282 [TBL] [Abstract][Full Text] [Related]
12. In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. Thillainayagam M; Malathi K; Ramaiah S J Biomol Struct Dyn; 2018 Nov; 36(15):3993-4009. PubMed ID: 29132266 [TBL] [Abstract][Full Text] [Related]
13. A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs. Jida M; Sanchez CP; Urgin K; Ehrhardt K; Mounien S; Geyer A; Elhabiri M; Lanzer M; Davioud-Charvet E ACS Infect Dis; 2017 Feb; 3(2):119-131. PubMed ID: 28183182 [TBL] [Abstract][Full Text] [Related]
14. Screening and Identification of Inhibitors Against Glutathione Synthetase, A Potential Drug Target of Plasmodium falciparum. Kumar YN; Jeyakodi G; Thulasibabu R; Gunasekaran K; Jambulingam P Comb Chem High Throughput Screen; 2015; 18(5):492-504. PubMed ID: 26220832 [TBL] [Abstract][Full Text] [Related]
15. Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics. Araujo JSC; de Souza BC; Costa Junior DB; Oliveira LM; Santana IB; Duarte AA; Lacerda PS; Dos Santos Junior MC; Leite FHA J Mol Model; 2018 Jul; 24(8):220. PubMed ID: 30056475 [TBL] [Abstract][Full Text] [Related]
16. Competitive Inhibition of Okanin against Yang G; Liang Y; Li X; Li Z; Qin Y; Weng Q; Yan Y; Cheng Y; Qian Y; Sun L Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731970 [TBL] [Abstract][Full Text] [Related]
17. Exploring the trifluoromenadione core as a template to design antimalarial redox-active agents interacting with glutathione reductase. Lanfranchi DA; Belorgey D; Müller T; Vezin H; Lanzer M; Davioud-Charvet E Org Biomol Chem; 2012 Jun; 10(24):4795-806. PubMed ID: 22618151 [TBL] [Abstract][Full Text] [Related]
18. Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum. Friebolin W; Jannack B; Wenzel N; Furrer J; Oeser T; Sanchez CP; Lanzer M; Yardley V; Becker K; Davioud-Charvet E J Med Chem; 2008 Mar; 51(5):1260-77. PubMed ID: 18260613 [TBL] [Abstract][Full Text] [Related]
19. In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria. Wadood A; Ghufran M; Hassan SF; Khan H; Azam SS; Rashid U Pharm Biol; 2017 Dec; 55(1):19-32. PubMed ID: 27650666 [TBL] [Abstract][Full Text] [Related]